Regulation of receptors for atrial natriuretic peptide in the rat and human.
Atrial natriuretic factor or peptide (ANP) is a peptide recently isolated from mammalian atria with potent natriuretic, vasorelaxant, and aldosterone-inhibitory properties. ANP may play an important role in the regulation of blood pressure and body salt and fluid balance. The presence of binding sites for ANP in the vasculature and adrenal glomerulosa of rats and in platelets in humans has been demonstrated. These sites are involved in the mediation of the vasorelaxant effect of ANP and its inhibitory action on aldosterone secretion. The role of binding sites on platelets is unknown, but the availability of platelets makes them a useful model for investigating the regulation of receptors for atrial natriuretic factor in humans. The effect of sodium depletion and loading and mineralocorticoids on the density of rat vascular and adrenal sites for ANP was examined, as well as changes that occur after development of renovascular and DOCA-salt hypertension in rats. Sodium loading in the presence of reduced renal mass (unilateral nephrectomy) or mineralocorticoid administration produced renin suppression and resulted in down-regulation of vascular ANP receptors. In one-kidney, one-clip Goldblatt hypertensive rats and in DOCA-salt hypertensive rats, two models of volume-expanded, non-renin-dependent experimental hypertension, the density of ANP binding sites in the mesenteric arterioles was significantly decreased. The sensitivity to ANP of precontracted aorta from renovascular and mineralocorticoid hypertensive rats was significantly reduced. No consistent changes occurred in the density of ANP binding sites in the adrenal glomerulosa.(ABSTRACT TRUNCATED AT 250 WORDS)